Cited in | Search | Type: | Patent literature | Publication No.: | EP2228058
[A] (NOVAGALI PHARMA SA [FR]) [A] 1-16 * paragraph [0005] * * page 3, line 17 * * page 3, line 20 - line 22 * * page 3, line 33 - line 34 * * paragraph [0020] *; | Type: | Non-patent literature | Publication information: | [A] - HEE YOUNG CHOI ET AL, "In Vitro Study of Antiadipogenic Profile of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in Human Orbital Preadiopocytes", JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS., US, (201204), vol. 28, no. 2, doi:10.1089/jop.2011.0160, ISSN 1080-7683, pages 146 - 152, XP055131156 [A] 1-16 * the whole document * | DOI: | http://dx.doi.org/10.1089/jop.2011.0160 | Cited in | by applicant | Type: | Patent literature | Publication No.: | US2010234466
| Type: | Patent literature | Publication No.: | WO2012099942
| Type: | Patent literature | Publication No.: | US8426471
| Type: | Non-patent literature | Publication information: | - "Delivery System Design in Topically Applied Formulations: An Overview", DAYAN N, Delivery System Handbook for Personal Care and Cosmetic Products, WILLIAM ANDREW, (2005), pages 103 - 104 | Type: | Non-patent literature | Publication information: | - "In Vitro Assessment of Dermal Absorption", KAO J, Dermal and Ocular Toxicology: Fundamentals and Methods, CRC PRESS, (1991), pages 272 - 273 | Type: | Non-patent literature | Publication information: | - WILEN, S.H. ET AL., TETRAHEDRON, (1977), vol. 33, page 2725 | Type: | Non-patent literature | Publication information: | - WILEN, S.H., Tables of Resolving Agents and Optical Resolutions, UNIV. OF NOTRE DAME PRESS, (1972), page 268 | Type: | Non-patent literature | Publication information: | - T. PHARMACEUTICAL SCIENCES, (1977), vol. 66, pages 1 - 19 | Type: | Non-patent literature | Publication information: | - BARRETT CW, "Skin penetration", J. SOC. COSMETIC CHEMISTS, (1969), vol. 20, pages 487 - 499 | Type: | Non-patent literature | Publication information: | - BLUME-PEYTAVI U ET AL., "A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia", JAM ACAD DERMATOL, (2012), vol. 66, doi:doi:10.1016/j.jaad.2011.05.026, pages 794 - 800, XP055372723 | DOI: | http://dx.doi.org/10.1016/j.jaad.2011.05.026 | Type: | Non-patent literature | Publication information: | - SHARIF ET AL., J. OCULAR PHARMACOL. THER., (2002), vol. 18, pages 313 - 324 |